糖尿病護理設備的全球市場 (2023-2030年):產品 (血糖監測系統設備)·各終端用戶的規模·佔有率·成長分析·預測

Global Diabetes Care Devices Market Size, Share, Growth Analysis, By Product(Blood glucose monitoring devices), By End-use - Industry Forecast 2023-2030

出版日期: 2023年07月12日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球糖尿病護理設備的市場規模在2021年估算為267億美元，從2022年的290億2,000萬美元，在預測期間中將以8.7％的年複合成長率推移，成長到2030年565億7,000萬美元的規模。

由於全球糖尿病患病率不斷上升，全球糖尿病護理設備市場正在顯著增長。這些設備有助於管理和監測血糖水平，改善患者的治療結果。技術進步、糖尿病管理意識的提高以及老年人口的增長等因素人口正在推動市場增長。由於對糖尿病護理的微創和便攜式設備的需求不斷增長，預計未來幾年市場將繼續擴大。

本報告提供全球糖尿病護理設備的市場調查，彙整市場概要，市場的各種影響因素的分析，技術·革新趨勢，法律制度，市場規模的轉變·預測，各種區分·各地區的明細，競爭情形，主要企業簡介等資訊。

摘要整理
調查手法
母市場分析
市場概要
市場規模
市場動態
- 促進因素
- 機會
- 阻礙因素
- 課題
主要市場洞察
- 技術分析
- 價格分析
- 供應鏈分析
- 價值鏈分析
- 市場生態系統
- IP分析
- 貿易分析
- Start-Ups分析
- 原料分析
- 革新矩陣
- 開發中產品的分析
- 宏觀經濟指標
- 主要投資分析
- 主要成功因素
- 競爭的程度
市場動態·預測
- 市場動態
  - 促進因素
  - 機會
  - 阻礙因素
  - 課題
法規情形
波特分析
Skyquest對未來阻礙的特別見解
全球糖尿病護理設備市場:各產品
- 市場概要
- 血糖監測系統設備
  - 自我血糖監測系統設備
  - 持續血糖監測儀
  - 試驗帶
  - 採血針
- 胰島素通知設備
  - 胰島素幫浦
  - 管附著幫浦
  - 無內胎泵
  - 筆 (可重複使用·拋棄式)
  - 筆型針頭 (標準·安全性)
  - 注射器
  - 其他
全球糖尿病護理設備市場:各終端用戶
- 市場概要
- 醫院
- 門診病人手術中心
- 診斷中心
- 居家照護
- 診所
- 其他
全球糖尿病護理設備市場:各地區
- 市場概要
- 北美
- 歐洲
- 亞太地區
- 南美
- 中東·非洲
競爭情形
- 前五名公司的比較
- 主要企業的市場上的地位
- 主要企業的招聘策略
- 主要成功策略
- 市場上最近的活動
- 主要企業的市場佔有率
- 主要企業簡介
  - Abbott Laboratories
  - Ascensia Diabetes Care
  - Becton, Dickinson and Company
  - Dexcom, Inc.
  - Eli Lilly and Company
  - F. Hoffmann-La Roche AG
  - Insulet Corporation
  - Johnson & Johnson
  - Medtronic plc
  - Nova Biomedical
  - Novo Nordisk A/S
  - Omron Healthcare, Inc.
  - Sanofi S.A.
  - Tandem Diabetes Care, Inc.
  - Terumo Corporation
  - Trividia Health, Inc.
  - Ypsomed AG
  - ARKRAY Inc.
  - Glooko, Inc.
  - GlySens Incorporated

簡介目錄

Product Code: SQSG35B2039

Diabetes Care Devices Market size was valued at USD 26.7 billion in 2021 and is poised to grow from USD 29.02 billion in 2022 to USD 56.57 billion by 2030, growing at a CAGR of 8.7% in the forecast period (2023-2030).

The global diabetes care devices market is witnessing significant growth due to the rising prevalence of diabetes worldwide. These devices help in managing and monitoring blood glucose levels, improving patient outcomes. Factors such as technological advancements, increasing awareness about diabetes management, and the growing geriatric population are driving market growth. The market is expected to continue expanding in the coming years, driven by the increasing demand for minimally invasive and portable devices for diabetes care.

Top-down and bottom-up approaches were used to estimate and validate the size of Diabetes Care Devices and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report:

Diabetes Care Devices Market is segmented on the basis of product type, end user, and region. By product, the Diabetes Care Devices Market segment is divided into blood glucose monitoring devices and insulin delivery devices. Blood glucose segment is further segmented into self-monitoring blood glucose meters, continuous glucose monitors, testing strips, and lancets. Insulin delivery devices are further segmented into insulin pumps (tubed pumps and tubeless pumps), pens (reusable and disposable), pen needles (standard and safety), syringes, and others. By end use, the market is segmented into hospitals, ambulatory surgery centers, diagnostic centers, home care, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and MEA.

Driver

The market is experiencing growth due to the increasing use of insulin-delivery devices and the growing prevalence of diabetes. Sedentary lifestyles and unhealthy choices have resulted in a rising number of Type-2 diabetes diagnoses. According to the International Diabetes Federation (IDF), approximately 537 million adults worldwide have diabetes, which can lead to the development of various chronic diseases. Consequently, there is a significant need to effectively manage and control diabetes.

Restrain

the global diabetes care devices market may encounter obstacles during the forecast period. Limited access to these devices in underdeveloped regions and challenges related to registration processes and reimbursement issues are expected to restrict market growth.

Trend

The growth of the diabetes monitoring devices segment is primarily driven by the increased adoption of test strips, self-monitoring blood glucose meters, and the growing demand for continuous glucose monitoring. Developing countries are witnessing a rise in awareness about the disease, contributing to this trend. The World Health Organization (WHO) reports that over 60% of the global population lacks sufficient physical activity. Active employment is considered vital for maintaining a healthy lifestyle, and the risk of developing type 2 diabetes increases with higher body weight across all age groups. As individuals become more health-conscious, the global market offers lucrative growth opportunities for industry players.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
- Regulatory Landscape
- Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global Diabetes Care Devices Market by Product
- Market Overview
- Blood glucose monitoring devices (Self-monitoring blood glucose meters
- continuous glucose monitors
- testing strips
- lancets)
- Insulin Delivery Devices (Insulin delivery devices {insulin pumps-tubed pumps
- tubeless pumps}
- pens{reusable
- disposable}
- pen needles {standard
- safety}
- syringes
- others)
Global Diabetes Care Devices Market by End-use
- Market Overview
- Hospitals
- ambulatory surgery centres
- diagnostic centres
- home care
- clinics
- others
Global Diabetes Care Devices Market Size by Region
- Market Overview
- North America
USA
Canada
- Europe
Germany
Spain
France
UK
Rest of Europe
- Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
- Latin America
Brazil
Rest of Latin America
- Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
By Development
By Company
By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Abbott Laboratories
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Ascensia Diabetes Care
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Becton, Dickinson and Company
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Dexcom, Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Eli Lilly and Company
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- F. Hoffmann-La Roche AG
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Insulet Corporation
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Johnson & Johnson
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Medtronic plc
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Nova Biomedical
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Novo Nordisk A/S
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Omron Healthcare, Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Sanofi S.A.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Tandem Diabetes Care, Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Terumo Corporation
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Trividia Health, Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Ypsomed AG
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- ARKRAY Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Glooko, Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- GlySens Incorporated
Company Overview
Business Segment Overview
Financial Updates
Key Developments